News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Akhil Santhosh: Strategies to improve beyond KATHERINE
Akhil Santhosh
May 9, 2025, 15:40

Akhil Santhosh: Strategies to improve beyond KATHERINE

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post on X:

“Strategies to improve beyond KATHERINE
1. ASTEFANIA: TDM1+/-Atezolizumab
2. COMPASS HER2 RD: TDM1+/-Tucatinib
3. Destiny breast 05: TDM1 vs TdXD “

KATHERINE

More posts featuring Akhil Santhosh

Akhil Santhosh Breast Cancer cancer KATHERINE OncoDaily Oncology
Special Coverage
Career
May 29, 2025, 19:02
Vincent Rajkumar: Thrilled Saad Usmani Will Receive the Giants of Cancer Care Award for Myeloma
Blog
May 29, 2025, 18:50
Narjust Florez: A Few Things I Wish I Knew as a Fellow While Starting the ASCO Journey
Science
May 29, 2025, 18:39
Melvin Chua: Progress in Focal Therapy for Prostate Cancer Can Be Made by Good Science
Blog
May 29, 2025, 18:26
Bench To Bedside on Drug Development for Rare and Economically Infeasible Cancers - FDA Oncology
Career
May 29, 2025, 18:16
The First 2025 Mentor of the Year Nominee: Mariana Chavez Mac Gregor - WinC - AlinC
Blog
May 29, 2025, 18:11
Manmeet Ahluwalia: Honored to Receive the Ellis Island Medal of Honor for Contributions to American Society
Positive
May 29, 2025, 17:58
Stephen Liu: Congratulations to the Newly Elected IASLC Board Members
Blog
May 29, 2025, 17:45
3D Printing in Radiation Oncology Workshop - ESTRO
Blog
May 29, 2025, 17:41
Amol Akhade: Can Perioperative Immunotherapy Change Outcomes in Resectable Gastric/GEJ Cancer?
Blog
May 29, 2025, 17:39
Patrick Ma: Looking Forward to ASCO 2025
Blog
May 29, 2025, 17:28
Sarbajit Mukherjee: Academic GI Oncology Opportunity - Let’s Meet at ASCO 2025
Science
May 29, 2025, 17:28
Praveen Kumar Marimuthu: RWD Shows NACT Plus Immunotherapy Nearly Doubles pCR in MIBC